SHC Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
324.9M
+1.1%
321.4M
+14.8%
280.0M
-7.7%
303.4M
-2.5%
311.3M
Cost of Revenue
144.1M
+0.5%
143.4M
+7.8%
133.0M
-3.3%
137.5M
+2.8%
133.8M
Gross Profit
180.8M
+1.6%
178.0M
+21.0%
147.1M
-11.4%
165.9M
-6.6%
177.6M
Operating Expenses
67.1M
-5.7%
71.2M
-0.1%
71.2M
+1716.9%
-4406000
-106.6%
66.4M
R&D
0
0
0
0
0
SG&A
64.1M
-5.9%
68.2M
-0.1%
68.2M
+18.6%
57.5M
-9.1%
63.3M
Operating Income
113.6M
+6.4%
106.8M
+40.8%
75.8M
-55.5%
170.3M
+53.2%
111.2M
EBITDA
146.2M
+4.3%
140.2M
+31.5%
106.6M
-22.7%
137.9M
-1.2%
139.5M
Net Income
58.4M
+8.9%
53.6M
+101.7%
26.6M
-23.7%
34.8M
-28.0%
48.4M
EPS (Basic)
$0.20
+5.3%
$0.19
+111.1%
$0.09
-25.0%
$0.12
-29.4%
$0.17
EPS (Diluted)
$0.20
+5.3%
$0.19
+111.1%
$0.09
-25.0%
$0.12
-29.4%
$0.17
Shares (Diluted)
289.2M
+0.4%
288.1M
+0.2%
287.6M
-0.7%
289.6M
+1.0%
286.7M
Sotera Health (SHC) — Financials